On June 24, 2025, RenovoRx, Inc. held its annual stockholder meeting, where 20,086,518 shares voted on three key proposals, including the election of directors and amendments to the equity incentive plan, and auditor ratification with substantial support. The stockholders approved an increase of 913,794 shares to the incentive plan, equating to 2.5% of shares outstanding, and ratified the auditors with over 19 million votes in favor.